Davern Capital Partners, LP

NY, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$514.1M2026 Q3
Positions17
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.81.3%

Davern Capital Partners, LP reported 17 positions worth $514.1M as of September 30, 2026 (13F filed November 12, 2026). Largest holding: BNTX (13.0%). Biggest move: reduce REGN ($39.4M).

10 / 17 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 BNTXBioNTech$67.1M13.04%682,148——-13.3%
▸ 2 RPRXRoyalty Pharma$56.9M11.06%974,412——+17.4%
▸ 3 INSMInsmed$56.6M11.01%496,047——+7.7%
▸ 4 ROIVRoivant Sciences$53.9M10.48%1,472,808——+5.6%
▸ 5 IONSIonis Pharmaceuticals$48.5M9.44%1,087,142——-37.3%
▸ 6 ARGXArgenx$36.1M7.01%37,597——-0.8%
▸ 7 REGNRegeneron Pharmaceuticals$30.8M6.00%40,661——+25.6%
▸ 8 NTRANatera$26.1M5.08%63,200——-30.2%
▸ 9 ABVXAbivax S.A.$21.7M4.22%219,183———
▸ 10 VERAVera Therapeutics$20.3M3.95%628,274——-13.0%

Pro Feature

The remaining 7 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Davern Capital Partners, LP hold as of Q3 2026?

Davern Capital Partners, LP reported 17 positions worth $514.1M in its Q3 2026 13F filing. Largest positions: BNTX (13.0%), RPRX (11.1%), INSM (11.0%), ROIV (10.5%) and IONS (9.4%).

What did Davern Capital Partners, LP buy in Q3 2026?

New positions: ARGX, ABVX, ARWR, LLY and VRDN. Added to: IONS, VERA and AVTX.

What did Davern Capital Partners, LP sell in Q3 2026?

Reduced: REGN, NTRA, ROIV, RPRX and INSM (8 in all). Sold out entirely: ALNY, GPCR and PRCT.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.